Vira-A
"Sometimes the juice ain't worth the squeeze... especially when combining grapefruit with medicines.
While it can be part of a balanced and nutritious diet, grapefruit can have serious consequences when taken with certain medications. Cu"...
Vira-A
(Generic versions may still be available.)
Vira-A Side Effects Center
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Vira-A in Detail - Patient Information: Side Effects
Serious side effects are not expected to occur with the use of this medication.
Commonly, some burning, stinging, pain, irritation, itching, redness, blurred vision, tearing, or sensitivity to light may occur. Continue to use vidarabine and talk to your doctor about any side effects that you experience.
Read the entire detailed patient monograph for Vira-A (Vidarabine) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Vira-A FDA Prescribing Information: Side Effects
(Adverse Reactions)
SIDE EFFECTS
Lacrimation, foreign body sensation, conjunctival injection, burning, irritation, superficial punctate keratitis, pain, photophobia, punctal occlusion, and sensitivity have been reported with VIRA-A (vidarabine) Ophthalmic Ointment, 3%. The following have also been reported but appear disease-related: uveitis, stromal edema, secondary glaucoma, trophic defects, corneal vascularization, and hyphema.
Read the entire FDA prescribing information for Vira-A (Vidarabine) »
Additional Vira-A Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






